Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Axcan Pharma Inc. (NasdaqNM:AXCA)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | Msgs
Location
597 Laurier Blvd., Quebec, J3H 6C4
Mont Saint-Halaire, Canada
Phone: (450) 467-2600
Fax: (450) 464-9979
Email: iadjahi@axcan.com
Employees (last reported count): 92
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Major Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 1%
·Institutional: 33% (33% of float)
(27 institutions)
·Net Inst. Buying: 1.61M shares (+12.49%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Axcan Pharma Inc. is a North American pharmaceutical company within the field of gastroenterology. Axcan markets a broad line of pharmaceutical products used in the treatment of a variety of gastrointestinal diseases and disorders. Axcan carries out research and development of products at an advanced stage of development that it acquires or licenses from third parties. Axcan is currently developing five products for nine indications, eight of which are in phase II or III studies, and one for which a New Drug Application has been submitted to the Food and Drug Administration. The Company's products are marketed in Canada and, through its subsidiary Scandipharm Inc., in the United States. Axcan is also a 50% owner of Althin Biopharm Inc., which supplies equipment and hemodialysis products for patients suffering from renal failure. In addition, Axcan holds a 50% interest in Bonne Sante z.o.o. and CZET Pharma, two companies that distribute pharmaceutical products in Poland.
More from Market Guide: Expanded Business Description

Financial Summary
Axcan Pharma Inc. is a pharmaceutical company dedicated to the research, the development, the production and the marketing of innovative products in the field of gastroenterology. For the nine months ended 6/30/01, revenues rose 21% to $76.1 million. Net income from continuing operations totaled $7.1 million, up from $2.5 million. Revenues reflect an increase in sales of PHOTOFRIN, a product acquired in June 2000. Net income also reflects lower interest expenses.
More from Market Guide: Significant Developments

Officers

Position
Leon GosselinPres, CEO, Director
Lisa Page NelsonManaging Director
Jacques GauthierDirector, Bus. Conultant
Colin MalletDirector, Bus. Consultant
David MimsExec. VP, COO, Director
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:AXCAAs of 31-Aug-2001
Price and Volume
52-Week Low
on 15-Mar-2001
$8.313
Recent Price$11.16 
52-Week High
on 5-Sep-2000
$16.25 
Daily Volume (3-month avg)36.4K
Daily Volume (10-day avg)34.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-7.0%
52-Week Change
relative to S&P500
+24.8%
Share-Related Items
Market Capitalization$385.2M
Shares Outstanding34.5M
Float34.2M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$5.60 
Earnings (ttm)$0.27 
Earnings (mrq)$0.08 
Sales (ttm)$2.87 
Cash (mrq)$0.34 
Valuation Ratios
Price/Book (mrq)1.99 
Price/Earnings (ttm)41.33 
Price/Sales (ttm)3.88 
Income Statements
Sales (ttm)$100.0M
EBITDA (ttm)$31.9M
Income available to common (ttm)$9.39M
Profitability
Profit Margin (ttm)9.5%
Operating Margin (ttm)15.6%
Fiscal Year
Fiscal Year EndsSep 30
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)3.84%
Return on Equity (ttm)5.61%
Financial Strength
Current Ratio (mrq)2.71 
Debt/Equity (mrq)0.00 
Total Cash (mrq)$12.3M
Short Interest
As of 8-Aug-2001
Shares Short0 
Shares Short
(Prior Month)
3,000 
Daily Volume17.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.